DocMorris (DOCM) Stock Overview
Operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
DOCM Community Fair Values
Create NarrativeSee what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.
DocMorris AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 5.50 |
| 52 Week High | CHF 30.18 |
| 52 Week Low | CHF 4.79 |
| Beta | 1.78 |
| 1 Month Change | -0.45% |
| 3 Month Change | -15.40% |
| 1 Year Change | -81.37% |
| 3 Year Change | -82.49% |
| 5 Year Change | -97.91% |
| Change since IPO | -96.56% |
Recent News & Updates
Is DocMorris (VTX:DOCM) Using Too Much Debt?
Oct 23
A Piece Of The Puzzle Missing From DocMorris AG's (VTX:DOCM) 28% Share Price Climb
Aug 06Recent updates
Is DocMorris (VTX:DOCM) Using Too Much Debt?
Oct 23A Piece Of The Puzzle Missing From DocMorris AG's (VTX:DOCM) 28% Share Price Climb
Aug 06Positive Sentiment Still Eludes DocMorris AG (VTX:DOCM) Following 33% Share Price Slump
Jun 15DocMorris AG (VTX:DOCM) Stock Rockets 35% But Many Are Still Ignoring The Company
May 01Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?
Apr 11The DocMorris AG (VTX:DOCM) Yearly Results Are Out And Analysts Have Published New Forecasts
Mar 16Sentiment Still Eluding DocMorris AG (VTX:DOCM)
Mar 14It's Down 30% But DocMorris AG (VTX:DOCM) Could Be Riskier Than It Looks
Dec 10DocMorris AG's (VTX:DOCM) Subdued P/S Might Signal An Opportunity
Oct 25Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?
Sep 22Would Zur Rose Group (VTX:ROSE) Be Better Off With Less Debt?
Sep 07We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt
Dec 05We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt
Aug 22Shareholder Returns
| DOCM | CH Consumer Retailing | CH Market | |
|---|---|---|---|
| 7D | 11.1% | 0.4% | 1.6% |
| 1Y | -81.4% | 5.0% | 7.0% |
Return vs Industry: DOCM underperformed the Swiss Consumer Retailing industry which returned 5% over the past year.
Return vs Market: DOCM underperformed the Swiss Market which returned 7% over the past year.
Price Volatility
| DOCM volatility | |
|---|---|
| DOCM Average Weekly Movement | 6.5% |
| Consumer Retailing Industry Average Movement | 3.9% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in CH Market | 7.5% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: DOCM's share price has been volatile over the past 3 months compared to the Swiss market.
Volatility Over Time: DOCM's weekly volatility has decreased from 12% to 7% over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 1,454 | Walter Hess | corporate.docmorris.com/en |
DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. It offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions.
DocMorris AG Fundamentals Summary
| DOCM fundamental statistics | |
|---|---|
| Market cap | CHF 267.05m |
| Earnings (TTM) | -CHF 120.87m |
| Revenue (TTM) | CHF 1.06b |
Is DOCM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOCM income statement (TTM) | |
|---|---|
| Revenue | CHF 1.06b |
| Cost of Revenue | CHF 831.97m |
| Gross Profit | CHF 230.27m |
| Other Expenses | CHF 351.15m |
| Earnings | -CHF 120.87m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Mar 19, 2026
| Earnings per share (EPS) | -2.49 |
| Gross Margin | 21.68% |
| Net Profit Margin | -11.38% |
| Debt/Equity Ratio | 59.5% |
How did DOCM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/01 07:43 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
DocMorris AG is covered by 18 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Sarah Roberts | Barclays |
| Gerhard Orgonas | Berenberg |